Status:
WITHDRAWN
Azelastine Fluticasone Combination vs. Fluticasone
Lead Sponsor:
University of Dundee
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to see how a combination spray of azelastine and fluticasone (antihistamine and steroid) compares with a steroid nasal spray (fluticasone) alone in allergic rhinitis i.e. ...
Detailed Description
Allergic rhinitis (AR) is a major chronic respiratory disease with a prevalence approaching nearly 25% in the worldwide population.Allergic Rhinitis is a common and relatively undiagnosed public healt...
Eligibility Criteria
Inclusion
- Male of Female aged 18-65 years.
- Persistent allergic rhinitis with or without asthma.
- Atopy to at least one allergen on SPT.
- Ability to give a written informed consent.
- Ability and willingness to comply with the requirements of the protocol.
Exclusion
- Recent respiratory tract/sinus infection within the last 2 months. .
- Pregnancy, planned pregnancy or lactation.
- Known or suspected hypersensitivity to any of the IMP's.
- Concomitant use of medicines (prescribed, OTC or herbal) like alpha blockers that may interfere with the trial.
- Nasal Polyposis grade 2+, Deviated nasal septum ≥ 50%
- The use of oral corticosteroids within the last 3 months.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00845598
Start Date
August 1 2010
End Date
August 1 2011
Last Update
June 12 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ninewells Hospital and Medical School
Dundee, United Kingdom, DD1 9SY
2
Perth Royal Infirmary
Perth, United Kingdom, PH1 1NX